← Eichor
Study identifier: NCT07698132 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

HALO-TRIAL: High, Medium And LOw Intensity Psychotherapy for Binge Eating Disorder

Condition: Binge Eating Disorder · Binge Eating Episodes · Binge Eating/Loss of Control Eating  ·  Sponsor: Herlev and Gentofte Hospital

PhaseNA
Planned participants256
Who can joinAll sexes, 18 Years to 65 Years
Healthy volunteersNo

About this study

The HALO trial is designed as a four-armed, assessor-blinded, fidelity-monitored randomized clinical trial. The goal of this randomized controlled study is to investigate the effectiveness of four different psychotherapy programs and to determine which one is most effective in reducing the number of binge-eating episodes in people with the eating disorder Binge Eating Disorder (BED), by directly comparing three intensities of Cognitive Behavioral Therapy-Enhanced against a manualized treatment as usual. Participants will be asked to complete a 21-weeks randomized intervention and participate in follow up assesments.

This description comes directly from the study's public registry record.

Talk to the study team

Contact details are listed per location below or on the registry record.

Always discuss trial participation with your own doctor first.

Locations (1)

Mental Health Centre BallerupBallerup Municipality, Capital Region, DenmarkRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07698132